A Prospective, Single-arm Clinical Study of Blinatumomab in the Maintenance Treatment of High-risk Patients With Acute B-lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Latest Information Update: 30 Oct 2024
At a glance
- Drugs Blinatumomab (Primary)
- Indications B-cell leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 30 Oct 2024 New trial record